These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22440324)

  • 21. Growth and lipid metabolism in girls and young women with epilepsy during pubertal maturation.
    Mikkonen K; Knip M; Pakarinen AJ; Lanning P; Isojärvi JI; Vainionpää LK
    Epilepsia; 2005 Jul; 46(7):1114-20. PubMed ID: 16026564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and tolerability of zonisamide in children with epilepsy: a retrospective review.
    Tan HJ; Martland TR; Appleton RE; Kneen R
    Seizure; 2010 Jan; 19(1):31-5. PubMed ID: 19942456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum leptin and insulin resistance in obesity and effects of sibutramine on them].
    Wu J; Lei MX; Chen HL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):605-7. PubMed ID: 15804071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of zonisamide monotherapy in children with epilepsy.
    Seki T; Kumagai N; Maezawa M
    Seizure; 2004 Dec; 13 Suppl 1():S26-32; discussion S33. PubMed ID: 15511685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Our clinical experience with zonisamide in resistant generalized epilepsy syndromes.
    Kelemen A; Rásonyl G; Neuwirth M; Barcs G; Szucs A; Jakus R; Fabó D; Juhos V; Pálfy B; Halász P
    Ideggyogy Sz; 2011 Mar; 64(5-6):187-92. PubMed ID: 21688720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical activity is associated with risk factors for chronic disease across adult women's life cycle.
    Woolf K; Reese CE; Mason MP; Beaird LC; Tudor-Locke C; Vaughan LA
    J Am Diet Assoc; 2008 Jun; 108(6):948-59. PubMed ID: 18502225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practical prescribing and long-term efficacy and safety of zonisamide.
    Leppik IE
    Epilepsy Res; 2006 Feb; 68 Suppl 2():S17-24. PubMed ID: 16406743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term use of zonisamide in refractory childhood-onset epilepsy.
    Kluger G; Zsoter A; Holthausen H
    Eur J Paediatr Neurol; 2008 Jan; 12(1):19-23. PubMed ID: 17574461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zonisamide monotherapy for idiopathic epilepsy in dogs.
    Chung JY; Hwang CY; Chae JS; Ahn JO; Kim TH; Seo KW; Lee SY; Youn HY
    N Z Vet J; 2012 Nov; 60(6):357-9. PubMed ID: 22639873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leptin levels are associated with fat oxidation and dietary-induced weight loss in obesity.
    Verdich C; Toubro S; Buemann B; Holst JJ; Bülow J; Simonsen L; Søndergaard SB; Christensen NJ; Astrup A
    Obes Res; 2001 Aug; 9(8):452-61. PubMed ID: 11500525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective audit of adjunctive zonisamide in an everyday clinical setting.
    Stephen LJ; Kelly K; Wilson EA; Parker P; Brodie MJ
    Epilepsy Behav; 2010 Apr; 17(4):455-60. PubMed ID: 20207201
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
    Hasegawa H
    Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma levels of insulin and leptin in patients with morbid obesity and anorexia nervosa after weight loss or gain, respectively].
    Escobar L; Freire JM; Girón JA; Vázquez JM; Pajares M; Ortego J; Gavilán I; Chover AJ; Carrasco M; Epinosa R; Marín F; Aguilar M
    Rev Esp Med Nucl; 2000 Jun; 19(3):199-206. PubMed ID: 11062083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sympathetic-leptin relationship in obesity: effect of weight loss.
    Quilliot D; Böhme P; Zannad F; Ziegler O
    Metabolism; 2008 Apr; 57(4):555-62. PubMed ID: 18328360
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity among children and adolescents with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Simm D; Beier C; Dörr HG
    Pediatrics; 2006 Jan; 117(1):e98-105. PubMed ID: 16396852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leptin, superoxide dismutase, and weight loss: initial leptin predicts weight loss.
    Shih LY; Liou TH; Chao JC; Kau HN; Wu YJ; Shieh MJ; Yeh CY; Han BC
    Obesity (Silver Spring); 2006 Dec; 14(12):2184-92. PubMed ID: 17189545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating levels of allopregnanolone, a neuroactive steroid, and leptin during treatment with valproic acid in children with epilepsy.
    Grosso S; Luisi S; Mostardini R; Matera M; Barlocco EG; Casarosa E; Balestri P; Petraglia F
    Neuroendocrinology; 2011; 93(3):159-64. PubMed ID: 20980729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships between serum osteocalcin, leptin and the effect of weight loss by pharmacological treatment in healthy, nonsmoking Korean obese adults.
    Suh HS; Hwang IC; Lee KS; Kim KK
    Clin Chim Acta; 2013 Mar; 418():17-21. PubMed ID: 23247052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anthropometric indexes, insulin resistance, and serum leptin and lipid levels in women with cryptogenic epilepsy receiving topiramate treatment.
    Genc BO; Dogan EA; Dogan U; Genc E
    J Clin Neurosci; 2010 Oct; 17(10):1256-9. PubMed ID: 20598547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.